Bacterial resistance to antimicrobial agents in Latin America: The giant is awakening

Infectious Disease Clinics of North America

Volumn 14, Issue 1, 2000, Pages 67-81

  Guzmán Blanco, Manuel ^a   Casellas, José María ^b   Silva Sader, Helio ^c  

^a Hospital Vargas de Caracas   (Venezuela)

^b Sanatorio San Lucas   (Argentina)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; DOXYCYCLINE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METICILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; STREPTOGRAMIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; TROVAFLOXACIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; ENTEROCOCCUS; EPIDEMIC; HEALTH CARE ORGANIZATION; INTESTINE INFECTION; KLEBSIELLA PNEUMONIAE; MENINGOCOCCOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; REVIEW; SOUTH AND CENTRAL AMERICA; STREPTOCOCCUS INFECTION; URINARY TRACT INFECTION;

EID: 0034021868     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70218-X     Document Type: Article

References (59)

1. A. Bartoloni F. Cutts S. Ieoni Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia Trop Med Int Health 3 1998 116
2. J. Baraibar H. Correa D. Mariscal Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia Chest 112 1997 1050
3. A. Bauernfeind J.M. Casellas M. Goldberg A new plasmidic cefotaximase from patients infected with Salmonella typhimurium Infection 18 1992 141
4. A. Bauernfeind I. Stempliger R. Jungwirth Sequences of betalactamase genes encoding CTX-M-1 and CTX-M-2 and relationship of their amino acid sequences with those of other betalactamases Antimicrob Agents Chemother 40 1996 509
5. S. Brown C. Bantar Y. Kay Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2 Lancet 251 1998 186
6. Callejo R, Quinteros M, Gregorevsky J, et al: Meningitis meningocóccica en adultos durante el período 1994–1996. Resumen 1380. I congreso Internacional de Infectología y microbiologia Clínica (SADI-SADEBAC). Buenos Aires, Argentina, 1997
7. J.M. Casellas M. Guzman-Blanco M.E. Pinto The sleeping giant. Antimicrobial resistance Medical Clinics of North America 8 1994 29
8. J.M. Casellas Conceptos bacteriologicos en el manejo antibacteriano de las infecciones urinarias Garmaldi J.E. Cubektin A.M. Infecciones urinarias en la infancia y la adolescencia 1998 Ed universidad de Rio Cuarto Rio Cuarto, Argentina 471 479
9. J.M. Casellas Antimicrobianos en gineco-obstetricia Farinati A.E. Mormandi J.O. Tilli M. Infecciones en gineco-obstetricia 1998 Ed Color Press-Pfizer Buenos Aires, Argentina 59 119
10. J.M. Casellas M. Goldberg M.I. Morosini Estudio sobre cepas productoras de betalactamasas-plasmidicas de expectro expandido en Argentina Infectología y Microbiología Clínica 2 1990 14
11. J.M. Casellas M. Goldberg Incidence of strains producing extended spectrum beta-lactamases in Argentina Infection 17 1989 434
12. M. Comegna M. Guzman O. Carmona Sensibilidad a los antimicrobianos en Venezuela 1997–1998 Revista Panamericana de Infectologia 3 suppl 1 1999 S56
13. Dalla Costa L.M. D.C. Souza L.T.F. Martins Vancomycin-resistant Enterococcus faecium : First case in Brazil Brazilian Journal of Infectious Diseases 2 1998 160
14. Diekema DJ, Pfaller MA, Jones RN, et al, and the SENTRY Participants Group: Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis, in press
15. M.B. Edmond J.F. Ober J.L. Weinbaum Glycopeptide-resistant Enterococcus faecium bacteremia: risk factors for infection Clin Infect Dis 20 1995 1126
16. G.M. Eliopoulos Vancomycin-resistant enterococci Infect Dis Clin North Am 11 1997 851 865
17. D.H. Forster F.D. Daschner Acinetobacter species as nosocomial pathogens Eur J Clin Microbiol Infect Dis 17 1998 73
18. Galas M, Pasteran F, Melano R, et al: Unusual distribution of enzymatic resistance to third generation cephalosporins in E. coli in Argentina [abstract E-109]. In Programs and Abstracts of the 38th Interscience Congress Antimicrobial Agents Chemotherapy. San Diego, CA, 1998
19. Galas M, Petroni A, Melano R, et al: Plasmidic extended spectrum beta-lactamase in Vibrio cholerae O1 El Tor in Argentina [abstract C-174]. In Programs and Abstracts of the 38th Interscience Congress Antimicrobial Agents Chemotherapy. San Diego, CA, 1998
20. A.C. Gales A. Bolmström J. Sampaio Antimicrobial susceptibility of Klebsiella pneumoniae producing extended-spectrum β-lactamases (ESBL) isolated in Brazilian hospitals Braz J Infect Dis 1 1997 196
21. L. Gutmann B. Ferré F.W. Goldstein SHV-5, a novel SHV-type betalactamase that hydrolizes broad spectrum cephalosporins and monobactams Antimicrob Agents Chemother 33 1989 951
22. Hashimoto A, Silbert S, Reis A, et al: Antimicrobial susceptibility of gram-negative bacteria isolated from blood stream infections: Results from a Brazilian multicenter study. In Abstracts of the 99th General Meeting of the American Society for Microbiology. Chicago, IL, 1999
23. M. Hortal C. Bazet Matturo Infecciones intrahospitalarias en Uruguay: Resistencia a los antibióticos de los principales microorganismos identificados Rev Panam Infect 3 suppl 1 1999 S48
24. Kertesz D.A. Di Fabio J.L. M.C.C. Brandileone Invasive Streptococcus pneumoniae infection in Latin American children: Results of the Pan American Health Organization Surveillance study Clin Infect Dis 26 1998 1355
25. Leiza M.G. Pérez Diaz J. J. Ayala Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae , a new amp C-type plasmidic-mediated beta-lactamase Antimicrob Agents Chemother 38 1994 2150
26. L. Leon S. Fernandez E. Franco Identificacion de cepas de Neisseria meningitidis con sensibilidad disminuida a penicilina, asiladas a partir de liquido cefalorraquideo de pacientes con meningitis en Venezuela Boletin Sociedad Venezolana de Microbiologia 13 1993 13
27. D.M. Livermore Beta-lactamases in laboratory and clinical resistance Clin Microbiol Rev 8 1995 557
28. A. Llop I. Tamargo M. Perez Resistencia a los antimicrobianos y vigilancia epidemiológica en Cuba Rev Panam Infect 3 suppl 1 1999 S41
29. H. Lopardo C. Santander M. Ceinos Isolation of moderately penicillin-susceptible strains of Neisseria meningitidis in Argentina Antimicrob Agents Chemother 37 1993 1728
30. Lopardo H, Fernandez N, Fernandez-Cobo M, et al: Emergence of Salmonella enterica resistant to aminoglycosides and third generation cephalosporins in Argentina [abstract 2088]. In Programs and Abstracts of the 17th International Congress of Chemotherapy. Berlin, Germany, 1991
31. G. MacCracken Diagnosis and management of acute urinary tract infections in infants and children Pediatr Infect Dis J 6 1982 107
32. G. MacCracken Options in antimicrobial management of urinary tract infections in infants and children Pediatr Infect Dis J 8 1989 552
33. E. Maiorini E. López E. Morrow Multiple resistant nontyphoidal salmonella gastroenteritis in children Pediatr Infect Dis J 12 1993 131
34. M.E. Marin J.R. Mera R.C. Arduino First report of vancomycin-resistant Enterococcus faecium isolated in Argentina Clin Infect Dis 26 1998 235
35. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing Supplemental tables, M100-S9 1999 National Committee for Clinical Laboratory Standards Wayne, PA
36. Organización Panamericana de la Salud: Prevención y control de la resistencia a los antimicrobianos en las Americas. OPS/HCP/HCT/139/99. Washington, DC, 1999
37. R.D. Orrantia H. Silva D. Pontani El proyecto ARTEMIS: Un estudio sobre la actividad de algunos antibióticos de uso común para el tratamiento de las infecciones del tracto respiratorio en diez paises latinoamericanos Rev Panam Infectol 2 1998 68
38. PAHO: Surveys on antimicrobial resistance in Latin America. Available trough web page: www:paho.org , 1998
39. Paterson DL, Ko WC, Von Gottberg A, et al: Outcome of bacteremia due to extended spectrum beta-lactamase producing Klebsiella pneumoniae [abstract 788]. In Programs and Abstracts of the 36th Infectious Diseases Society of America. Denver, CO, 1998
40. M.A. Pfaller R.N. Jones G.V. Doern Survey of blood stream infections attributable to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program Diagn Microbiol Infect Dis 34 1999 283
41. Power P, Radicce M, Barberis C, et al: Beta lactamases in Morganella morgannii , characterization of extended spectrum beta lactamases. Eur J Clin Microbiol Infect Dis, in press
42. V. Prado M. O'Ryan Acute gastroenteritis in Latin America Infect Dis Clin North Am 8 1994 77
43. Quinteros M: Estado actual de las beta-lactamasas en Argentina [abstract A-44]. In Programs and Abstracts of the 8th Congreso Argentino de Microbiologia. Buenos Aires, Argentina, 1998
44. K. Rahal F. Wang J. Schindler Reports on surveillance of antimicrobial resistance in individual countries Clin Infect Dis 24 suppl 1 1997 S169
45. J. Rello M. Rue P. Jubert Survival in patients with nosocomial pneumonia: Impact of the severity of illness and the etiologic agent Crit Care Med 25 1997 1862
46. C. Robledo J. Robledo Panoramica de la resistencia a los antibioticos en Colombia Rev Panam Infect 3 suppl 1 1999 S26
47. H.S. Sader R.N. Jones Gales A.C. the SENTRY Latin America Study Group Antimicrobial susceptibility of patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Results from the SENTRY Antimicrobial Surveillance Program (1997) Diagn Microbiol Infect Dis 32 1998 289
48. H.S. Sader I. Mimica F. Rossi Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from 18 Brazilian hospitals by using the Etest Diagn Microbiol Infect Dis 28 1997 87
49. Sader HS, Jones RN, Winokur PL, et al: Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals. Results from the SENTRY Antimicrobial Surveillance Program (1997). Clin Microbiol Infect, in press
50. Sader HS, Sampaio JLM, Zoccoli C, et al: Summary of the SENTRY antimicrobial surveillance program results in three Brazilian medical centers for 1997. Braz J Infect Dis, in press
51. Sader HS, Jones RN, Ballow CH, et al, and the GSMART Study Group: Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: Results from the Global SMART (GSMART) Surveillance Study. Presented at the 99th General Meeting of the American Society for Microbiology, Chicago, IL, 1999
52. R. Salvatierra-Gonzalez M. Guzman-Blanco Conferencia panamericana de Resistencia Antimicrobiana en las Americas Rev Panam Infect 3 suppl 1 1999 S1
53. J. Sifuentes-Osorio J. Donis-Hernández R. Arredondo-García Informe sobre resistencia bacteriana: Estudio piloto en seis centros de México Rev Panam Infect 3 suppl 1 1999 S45
54. J.M. Stelling T.F. O'Brien Surveillance of antimicrobial resistance: The WHONET Clin Infect Dis 24 suppl 1 1997 S157
55. Suarez JA, Maggi G, Rivas M, et al: Estudio comparativo multicentrico sobre la susceptibilidad in vitro de nueve antibioticos orales para el tratamiento de infecciones urinarias [abstract 95]. In Programs and Abstracts IX Congreso panamericano de Infectologia. Guatemala, 1999
56. D. Talon B. Mulin C. Rouget Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa Am J Respir Crit Care Med 157 1998 978
57. O. Trucco V. Prado F. Valdivieso Vigilancia de la susceptibilidad antimicrobiana de cepas causantes de infecciones invasivas en 11 hospitales de Chile Rev Panam Infect 3 suppl 1 1999 S11
58. World Health Organization The use of essential drugs Sixth report of the WHO Expert Committee 1995 World Health Organization Geneva
59. J. Zurita Y. Espinoza J. Ayabaca Resistencia bacteriana en Ecuador Rev Panam Infect 3 suppl 1 1999 S41